The large negative feedback of PARN on PLD expression was attenuated in cancer cells, perhaps due to the effect of an as-yet-unidentified regulator (shown in Fig. 8), which supports the significant role of PLD in this disease, and relates to the relative higher level of cell invasiveness and metastatic potential found in breast cancers. Here, GPLD1 is linked to breast carcinoma.